Acute Respiratory Infection Protection- Incidence, risk factors and vaccine preventability of acute respiratory infections and their impact on quality of life, work ability and absence from work

Acute Respiratory Infection Protection- Incidence, risk factors and vaccine preventability of acute respiratory infections and their impact on quality of life, work ability and absence from work - ARIPro

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033415

Enrollment

600

Registered

2024-02-23

Start date

2024-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute respiratory infections (Covid, Influenza, RSV) in health care workers

Interventions

Group 1: Non-interventional study: Study period: 01. 04. 2024 – 31. 03. 2027 The study cohort will consist of 600 health care workers. These are divided into 5 different subgroups: I: no seasonal vacc

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: written consent, health care workers at the time of a SARA-CoV-2 infection, a SARS-CoV-2 vaccination or at the time of recruitment

Exclusion criteria

Exclusion criteria: missing or reviked consent, COVID-19- vaccination with a vaccine that was not authorised in the european union

Design outcomes

Primary

Measure	Time frame
Goals of the study: -Evaluation of the immunogenicity and the tolerability of the coadministration of COVID-19- and Influenza vaccine -Detection of the rate of seroconversions against SARS-CoV-2, Influenza and RSV in health care workers and the influencing factors -Evaluation of the impact of SARS-CoV-2, Influenza and RSV infections and vaccinations on quality of life (assessed by WHOQOL-BREF) sick days at work and ability to work -Observation of influencial facors on vaccination preferences in health care workers	—

Measure

Time frame

Goals of the study: -Evaluation of the immunogenicity and the tolerability of the coadministration of COVID-19- and Influenza vaccine -Detection of the rate of seroconversions against SARS-CoV-2, Influenza and RSV in health care workers and the influencing factors -Evaluation of the impact of SARS-CoV-2, Influenza and RSV infections and vaccinations on quality of life (assessed by WHOQOL-BREF) sick days at work and ability to work -Observation of influencial facors on vaccination preferences in health care workers

—

Countries

Germany

Contacts

Public ContactManuel Krone

Zentrale Einrichtung Krankenhaushygiene und Antimicrobial Stewardship

Krone_M@ukw.de+49 931 201-46710

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026